MY7500253A - Substituted 5-sulfamylbenzoic acids - Google Patents

Substituted 5-sulfamylbenzoic acids

Info

Publication number
MY7500253A
MY7500253A MY253/75A MY7500253A MY7500253A MY 7500253 A MY7500253 A MY 7500253A MY 253/75 A MY253/75 A MY 253/75A MY 7500253 A MY7500253 A MY 7500253A MY 7500253 A MY7500253 A MY 7500253A
Authority
MY
Malaysia
Prior art keywords
substituted
sulfamylbenzoic acids
sulfamylbenzoic
acids
Prior art date
Application number
MY253/75A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY7500253A publication Critical patent/MY7500253A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96Sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MY253/75A 1970-09-14 1975-12-30 Substituted 5-sulfamylbenzoic acids MY7500253A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7215670A 1970-09-14 1970-09-14

Publications (1)

Publication Number Publication Date
MY7500253A true MY7500253A (en) 1975-12-31

Family

ID=22105942

Family Applications (1)

Application Number Title Priority Date Filing Date
MY253/75A MY7500253A (en) 1970-09-14 1975-12-30 Substituted 5-sulfamylbenzoic acids

Country Status (14)

Country Link
JP (1) JPS5512422B1 (fr)
AT (1) AT323187B (fr)
AU (1) AU468590B2 (fr)
BE (1) BE772381A (fr)
CA (1) CA983489A (fr)
CH (2) CH552575A (fr)
ES (2) ES394830A1 (fr)
FR (1) FR2106514B1 (fr)
GB (1) GB1353357A (fr)
KE (1) KE2573A (fr)
MY (1) MY7500253A (fr)
NL (1) NL173400C (fr)
SE (1) SE401673B (fr)
ZA (1) ZA715851B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929803A (en) * 1974-05-28 1975-12-30 Pfizer Aryl carboxylic acids
WO1983000013A1 (fr) * 1980-11-10 1983-01-06 Mochida Pharm Co Ltd Composition medicinale possedant un effet anti-viral
SE8203877L (sv) * 1981-06-22 1982-12-23 Hodogaya Chemical Co Ltd Aminosulfonylbensoesyraderivat
EP0132540A1 (fr) * 1981-06-22 1985-02-13 Mochida Pharmaceutical Co., Ltd. Compositions antivirales
JPS58192863A (ja) * 1982-05-06 1983-11-10 Hodogaya Chem Co Ltd 新規アミノスルホニル安息香酸エステル誘導体
JPS6323210U (fr) * 1986-07-31 1988-02-16
DE3732374A1 (de) * 1987-09-25 1989-04-06 Basf Lacke & Farben Zink-, blei- und/oder calciumsalze von carbonsaeuren und deren verwendung als korrosionsschutzmittel
JPH0248510U (fr) * 1988-09-28 1990-04-04
EP1218341B1 (fr) * 1999-09-01 2005-08-24 Aventis Pharma Deutschland GmbH Derives de sulfonylcarboxamide, leur procede de production et leur utilisation comme medicaments
DE19941559A1 (de) * 1999-09-01 2001-03-15 Aventis Pharma Gmbh Verwendung von Bissulfonamiden zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidömie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH433378A (de) * 1962-03-09 1967-04-15 Ciba Geigy Verfahren zur Herstellung neuer Anthranilsäurederivate
FR1525352A (fr) * 1967-04-06 1968-05-17 Ile De France Procédé de préparation des acides 2-alcoxy-5-sulfamido-benzoïques

Also Published As

Publication number Publication date
CH569706A5 (fr) 1975-11-28
AT323187B (de) 1975-06-25
SE401673B (sv) 1978-05-22
ES421977A1 (es) 1976-05-01
BE772381A (fr) 1972-03-09
GB1353357A (en) 1974-05-15
ZA715851B (en) 1972-05-31
AU468590B2 (en) 1976-01-15
DE2145686B2 (de) 1977-07-07
FR2106514A1 (fr) 1972-05-05
KE2573A (en) 1975-10-31
NL173400B (nl) 1983-08-16
NL173400C (nl) 1984-01-16
FR2106514B1 (fr) 1975-08-01
CA983489A (en) 1976-02-10
NL7112598A (fr) 1972-03-16
AU3308471A (en) 1973-03-08
JPS5512422B1 (fr) 1980-04-02
ES394830A1 (es) 1974-12-01
DE2145686A1 (de) 1972-04-20
CH552575A (fr) 1974-08-15

Similar Documents

Publication Publication Date Title
HK42177A (en) Azapurinones
IL36363A (en) 5-azapyrimidine-nucleosides
HK13477A (en) Arylalkylsulphoxides
CA995229A (en) Mono-chromone-2-carboxylic acids
IL36191A0 (en) Disc-brakes
KE2573A (en) Substituted 5-sulfamylbenzoic acids
PH15381A (en) Halogen substituted mercaptoacylamino acids
IE35693L (en) 1 - phenoxy - 2 - hydroxy - 3 - hydroxyalkyl-aminopropanes
ZA713114B (en) Imidazolribosylcyclophosphate
HK86379A (en) 3-fluoroalanines
IL36747A0 (en) 3-sulfonamido-4-hydroxyphenyl-2-piperidylcarbinols
IL36155A (en) 3-amino-1-phenoxy-propan-2-olderivatives
GB1364569A (en) Cinecamera
IL36630A (en) 2-naphthyl-quinazolinones
CA948204A (en) Substituted beta-arylamidoacrylic acids
ZA715126B (en) Mono-chromone-2-carboxylic acids
ZA713113B (en) Substituted octahydroquinazoline-diones
ZA713698B (en) New sulfamylbenzoic acids
AU4883172A (en) Stick-classifying
IE34997B1 (en) 4-piperidylidene-benzocycloheptathiopenes
IE34900B1 (en) Hexahydroazepines
IL37003A0 (en) 6-deoxy-5-oxytetracycline-esters
AU460526B2 (en) Substituted biphenyleneacetic acids
CA832450A (en) Substituted chloro-sulphamylanthranilic acids
CA842264A (en) Substituted 4-phenyl-cyclohexene-carboxylic acids